Welcome to Antoxis
Antoxis is developing innovative approaches for the treatment of neurodegenerative conditions, cardiovascular disease, cancer and inflammatory disorders through its mitochondrial-targeted, redox technology platform.
The company's proprietary technology is based on novel structural modifications to naturally-occurring flavonoids, found in fruit and vegetables, that greatly enhances their bio-activity and cell protective properties, whilst also imparting better pharmaceutical characteristics. The company now has patents protecting hundreds of thousands of synthetic flavonoid-like molecules.
Antoxis is also engaged in the field of regenerative medicine where it is developing small molecules to influence cell processes, such as differentiation, and to improve the viability of transplanted cells by protecting against reperfusion damage and oxidative stress.
